Global Healthcare Interoperability Solutions Market Overview

Global Healthcare Interoperability Solutions Market was valued at USD 2.31 billion in 2021 and is expected to reach USD 5.24 billion by the year 2028, at a CAGR of 12.4%.

Health information has always been difficult to access and share securely. The nature of health data creates a paradox as it's tough to share since it's sensitive and demands a high level of privacy and security. Failure to access it when it's needed the most could have serious consequences. Inadequate awareness of an individual's or population's health needs can result in lower outcomes and higher expenditures due to a lack of interoperability. As the world's population ages and individuals live longer, interoperability and data exchange will become increasingly important for delivering good healthcare services. According to the Agency for Healthcare Research and Quality, two out of every three older Americans in the United States have at least two chronic behavioral or physical disorders. Treatment for patients with multiple chronic illnesses is projected to account for 66 percent of all healthcare costs in the United States. Similarly, the rate of chronic disorders is also expected to increase in other countries. Integration of healthcare systems is anticipated to help develop a better understanding of an individual patient record. Additionally, this will help governments to analyze population data to see trends and meet their citizens' needs thus, promoting the growth of the healthcare interoperability solutions market over the forecast period.

Market Dynamics and Key Factors in Healthcare Interoperability Solutions:

Drivers:

Interoperability in the healthcare industry has increased considerably in recent years. The introduction of healthcare IT interoperability regulations in several countries has spurred market growth. The ongoing trend toward value-based patient care, as well as the advent of innovative healthcare delivery models, are estimated to boost the adoption of healthcare interoperability solutions. Healthcare interoperability solutions are projected to benefit from the pressing need to curb increasing healthcare costs. The demand for healthcare services is being driven by rising healthcare expenditures across the globe. The key variables that contribute to rising healthcare expenses are the aging population, the growing prevalence of chronic diseases, rising drug prices, higher healthcare service costs, and increased expenditure on healthcare administration.

Healthcare spending is also influenced by prices; the cost of healthcare services has risen faster than the cost of other products and services in the economy. Despite increasing healthcare spending, the United States falls behind other nations in terms of health outcomes. In this scenario, value-based care can lower healthcare costs by preventing unnecessary emergency visits, standardizing processes for cost-effectiveness, reducing readmissions or unnecessary medical tests, eliminating administrative procedures or tests, and improving medical team coordination and access to services. Moreover, the need to ensure connectivity of medical equipment and systems throughout the care continuum is also driving demand for these solutions. Increased adoption of app integration, application programming interface integration, data integration, data cleansing, data interoperability, and data analytics solutions are propelling the growth of the healthcare interoperability solutions market over the forecast period. The efficient and secure transmission of data across the healthcare ecosystem will help digital health reach its optimal potential thereby, supporting the development of the market.

Restraints:

One of the major constraints to the adoption of interoperability solutions is the lack of standards for sending, receiving, and managing data between EHR systems. Data must be altered and filtered before it can be imported into another system due to mismatched types, unusual data fields, and proprietary formats. Delays and inaccuracies are caused by the lack of a uniform standard for capturing, transmitting, receiving, storing, and managing patient data. Understanding and correctly interpreting medical terms is even more difficult. A fully interoperable system requires many layers of integration (inter and intra-organizational) and is difficult to achieve thus, hampering the expansion of the healthcare interoperability solutions market over the forecast period.

Opportunities:

Many organizations are working actively to make the shift to value-based care models. Healthcare Interoperability solutions are set to thrive from the shift to value-based care. Due to a lack of information flow, redundancy of lab tests and diagnosis creates a significant increase in healthcare expenses. Interoperability ensures that data is available across diverse systems to eliminate redundancy. According to studies, the interoperability of healthcare systems has the potential to save billions of dollars. The key strategy to reduce healthcare expenses and improve health value is to invest in new digital services that support the patient process. These new digital services require seamless interaction among all healthcare stakeholders, creating demand for interoperability solutions thus, creating a lucrative opportunity for the market players.

Government agencies in countries such as the United States have made interoperability rules essential for healthcare organizations. Data integration and analytics solutions are in high demand due to factors such as policy requirements and government regulations. These factors are driving the adoption of healthcare IT applications, that will benefit healthcare interoperability system providers. Moreover, in developing regions governments are spending more to develop the healthcare infrastructure. In these regions, the growing number of patients is expected to create a larger volume of data. The rise in the adoption of automation technology, growing IT infrastructure, and increasing government fundings are some major factors favoring the adoption of healthcare interoperability solutions. This creates a profitable growth opportunity for market players.

Market Segmentation

By type, the software segment is set to grow at the highest CAGR over the analysis period. Software solutions are the core of healthcare interoperability solutions. With the changing healthcare delivery models, service providers are developing innovative software solutions. The growth of this segment is attributed to the rising need for seamless access to individual patient data coupled with the usage of healthcare IT technologies to improve patient satisfaction and quality of care. The growth of this segment is expected to have 11% CAGR over the analysis period and currently, this segment accounts for a 45.1% share of the global healthcare interoperability solutions market.

By deployment, the cloud-based segment is forecasted to have the highest share of the healthcare interoperability solutions market. Cloud services offer healthcare professionals the to access data of patients at any given time and location. Cloud-based solution providers ensure that access to data is given to an authorized user. Furthermore, healthcare providers are prioritizing cloud-based electronic health record (EHR) systems to facilitate better communication between applications. Hospitals, affiliated practices, and anyone involved in patient care can access cloud-based solutions through a single platform thus, driving the growth of the segment in the forecast period.

By interoperability level, the structural segment is expected to have the lion's share of the healthcare interoperability solutions market. In Structural interoperability or structured transport, all of the data is standardized to a specific format so that it can be read by multiple systems and devices. This data is organized in a particular manner that enables the receiving system to recognize specific data fields automatically. Structural interoperability is provided by data standards such as Fast Healthcare Interoperability Resources (FHIR0 and Health Level Seven (HL7), which allow records to be uniform, centralized, and easy to move between systems. E-prescribing allows prescribers and pharmacists to access the same data thus, stimulating the adoption of structural interoperability in healthcare.

By end-user, the hospital segment is expected to dominate the healthcare interoperability solutions market over the projected timeframe. The data generated by hospitals is more than other end-users. Moreover, the safe and secure exchange of data between hospitals or medical professionals has created a huge demand for interoperability solutions. The growing medical tourism, rising prevalence of chronic disorders, and the COVID-19 pandemic have made the transfer of data essential. Hospitals are also investing heavily to protect the data generated, as the volume of generated data is large cloud-based storage solutions are getting popular amid the COVID-19 pandemic. In addition, individuals prefer hospitals for any major surgery due to flexible reimbursement policies thus, strengthening the development of the healthcare interoperability solutions market.

Players Covered in Healthcare Interoperability Solutions market are :

• Allscripts Healthcare LLC (US)
• NXGN Management LLC (US)
• EMIS Health (UK)
• Epic Systems Corporation (US)
• Infor Inc. (US)
• ViSolve Inc. (US)
• Cerner Corporation (US)
• InterSystems Corporation (US)
• Orion Health Group Limited (New Zealand)
• Jitterbit Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• iNTERFACEWARE Inc (Canada)
• OSP Labs (US)

Regional Analysis of Healthcare Interoperability Solutions Market:

The healthcare interoperability solutions market in the Asia-Pacific region is anticipated to develop at the highest CAGR attributed to the growing government initiatives for eHealth, medical tourism, and the rising prevalence of chronic disorders. China, India, Japan, Indonesia, and Australia are the major economies driving the growth of the healthcare interoperability solutions market in this region. There has been a rise in government spending on the development of healthcare infrastructure. For instance, in India, the healthcare market is expected to reach USD 372 billion by the end of 2022. This estimates a growing number of patients, thereby a large generation of data. To reduce the overall cost associated with delayed diagnosis and treatment, governments are adopting healthcare interoperability solutions thus, supporting the growth of the market in this region.

The North American region is expected to dominate the healthcare interoperability solutions market in the forecast period attributed to the implementation of various healthcare reforms by the major economies in this region. For instance, the Patient Protection and Affordable Care Enhancement Act (HR 1425), was presented in the United States House of Representatives on June 22, 2020. The bill aimed to strengthen and expand the Affordable Care Act (ACA) in order to reduce healthcare costs. Healthcare companies and clinicians must utilize healthcare interoperability solutions and services to make their operations easier, improve clinical outcomes, and lower healthcare costs, according to this act.

The healthcare interoperability solutions market in the European region is anticipated to develop at a significant growth rate attributed to the growing demand for the integration and implementation of medical devices and HCIT solutions to provide patients with cost-effective and high-quality treatment. The demand for electronic health record (EHR) systems and the need for flexible access to eHealth systems have increased in this region. The EU launched the ISA2 program in 2016 to encourage the development of digital solutions for interoperable cross-border and cross-sector public services. With this initiative the EU prioritizes the development of a single digital platform to help the healthcare professionals, researchers, and companies to make most of the generated data thus, supporting the growth in this region.

Recent Industry Developments in Healthcare Interoperability Solutions Market:

• In November 2021, NextGen Healthcare Inc. announced the launch of the NextGen® Community Health Collaborative (NCHC). This initiative, the first of its kind, will provide data benchmarking, comparative analytics, and reporting services, as well as a platform for members to network and exchange best practices to promote the objective of community health.
• In November 2021, InterSystems released the HealthShare 2021.2, the most recent version of the InterSystems HealthShare® suite of connected health solutions. HealthShare 2021.2 fosters collaboration across the patient care team while improving usability and security with expanded data and functionality throughout the suite.

COVID-19 Impact on Healthcare Interoperability Solutions Market:

The pandemic has had a positive impact on the market for healthcare interoperability solutions, and this trend is projected to continue in the coming years. Pre-COVID, healthcare organizations faced issues with interoperability and inadequate data management, which were exacerbated during the pandemic. Clinicians missed key COVID-19 information due to interoperability issues, which resulted in patient treatment delays and clinicians' inability to accurately document patients' status. Due to the fast changes each day of the pandemic, data interchange was not only inadequate but also difficult to arrange. With novel coronavirus strains causing fresh COVID-19 outbreaks around the world, data exchange through interoperability becomes even more critical. Frontline providers and researchers require access to the most comprehensive data sets available to track the disease, determine which protocols are most effective, and stay ahead of the virus, from understanding a single patient's entire medical journey to analyzing aggregated data at the community level. To summarize, the COVID-19 pandemic has spurred the demand for interoperability solutions in the healthcare sector.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Deployment
 3.3 By Interoperability Levels
 3.4 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Healthcare Interoperability Solutions Market by Type
 5.1 Healthcare Interoperability Solutions Market Overview Snapshot and Growth Engine
 5.2 Healthcare Interoperability Solutions Market Overview
 5.3 Software
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Software: Grographic Segmentation
 5.4 Services
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Services: Grographic Segmentation

Chapter 6: Healthcare Interoperability Solutions Market by Deployment
 6.1 Healthcare Interoperability Solutions Market Overview Snapshot and Growth Engine
 6.2 Healthcare Interoperability Solutions Market Overview
 6.3 Cloud-Based
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cloud-Based: Grographic Segmentation
 6.4 On-Premise
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 On-Premise: Grographic Segmentation

Chapter 7: Healthcare Interoperability Solutions Market by Interoperability Levels
 7.1 Healthcare Interoperability Solutions Market Overview Snapshot and Growth Engine
 7.2 Healthcare Interoperability Solutions Market Overview
 7.3 Foundational
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Foundational: Grographic Segmentation
 7.4 Structural
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Structural: Grographic Segmentation
 7.5 Semantic
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Semantic: Grographic Segmentation
 7.6 Organizational
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Organizational: Grographic Segmentation

Chapter 8: Healthcare Interoperability Solutions Market by End-User
 8.1 Healthcare Interoperability Solutions Market Overview Snapshot and Growth Engine
 8.2 Healthcare Interoperability Solutions Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Grographic Segmentation
 8.4 Pharmacies
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Pharmacies: Grographic Segmentation
 8.5 Clinics
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Clinics: Grographic Segmentation
 8.6 Payers
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Payers: Grographic Segmentation
 8.7 Ambulatory Surgical Centres
  8.7.1 Introduction and Market Overview
  8.7.2 Historic and Forecasted Market Size (2016-2028F)
  8.7.3 Key Market Trends, Growth Factors and Opportunities
  8.7.4 Ambulatory Surgical Centres: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Healthcare Interoperability Solutions Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Healthcare Interoperability Solutions Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Healthcare Interoperability Solutions Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 ALLSCRIPTS HEALTHCARE LLC
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 NXGN MANAGEMENT LLC
 9.4 EMIS HEALTH
 9.5 EPIC SYSTEMS CORPORATION
 9.6 INFOR INC.
 9.7 VISOLVE INC.
 9.8 CERNER CORPORATION
 9.9 INTERSYSTEMS CORPORATION
 9.10 ORION HEALTH GROUP LIMITED
 9.11 JITTERBIT INC.
 9.12 KONINKLIJKE PHILIPS N.V.
 9.13 INTERFACEWARE INC.
 9.14 OSP LABS
 9.15 OTHER MAJOR PLAYERS

Chapter 10: Global Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Software
  10.2.2 Services
 10.3 Historic and Forecasted Market Size By Deployment
  10.3.1 Cloud-Based
  10.3.2 On-Premise
 10.4 Historic and Forecasted Market Size By Interoperability Levels
  10.4.1 Foundational
  10.4.2 Structural
  10.4.3 Semantic
  10.4.4 Organizational
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Hospitals
  10.5.2 Pharmacies
  10.5.3 Clinics
  10.5.4 Payers
  10.5.5 Ambulatory Surgical Centres

Chapter 11: North America Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Software
  11.4.2 Services
 11.5 Historic and Forecasted Market Size By Deployment
  11.5.1 Cloud-Based
  11.5.2 On-Premise
 11.6 Historic and Forecasted Market Size By Interoperability Levels
  11.6.1 Foundational
  11.6.2 Structural
  11.6.3 Semantic
  11.6.4 Organizational
 11.7 Historic and Forecasted Market Size By End-User
  11.7.1 Hospitals
  11.7.2 Pharmacies
  11.7.3 Clinics
  11.7.4 Payers
  11.7.5 Ambulatory Surgical Centres
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Software
  12.4.2 Services
 12.5 Historic and Forecasted Market Size By Deployment
  12.5.1 Cloud-Based
  12.5.2 On-Premise
 12.6 Historic and Forecasted Market Size By Interoperability Levels
  12.6.1 Foundational
  12.6.2 Structural
  12.6.3 Semantic
  12.6.4 Organizational
 12.7 Historic and Forecasted Market Size By End-User
  12.7.1 Hospitals
  12.7.2 Pharmacies
  12.7.3 Clinics
  12.7.4 Payers
  12.7.5 Ambulatory Surgical Centres
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Software
  13.4.2 Services
 13.5 Historic and Forecasted Market Size By Deployment
  13.5.1 Cloud-Based
  13.5.2 On-Premise
 13.6 Historic and Forecasted Market Size By Interoperability Levels
  13.6.1 Foundational
  13.6.2 Structural
  13.6.3 Semantic
  13.6.4 Organizational
 13.7 Historic and Forecasted Market Size By End-User
  13.7.1 Hospitals
  13.7.2 Pharmacies
  13.7.3 Clinics
  13.7.4 Payers
  13.7.5 Ambulatory Surgical Centres
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Software
  14.4.2 Services
 14.5 Historic and Forecasted Market Size By Deployment
  14.5.1 Cloud-Based
  14.5.2 On-Premise
 14.6 Historic and Forecasted Market Size By Interoperability Levels
  14.6.1 Foundational
  14.6.2 Structural
  14.6.3 Semantic
  14.6.4 Organizational
 14.7 Historic and Forecasted Market Size By End-User
  14.7.1 Hospitals
  14.7.2 Pharmacies
  14.7.3 Clinics
  14.7.4 Payers
  14.7.5 Ambulatory Surgical Centres
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Healthcare Interoperability Solutions Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Software
  15.4.2 Services
 15.5 Historic and Forecasted Market Size By Deployment
  15.5.1 Cloud-Based
  15.5.2 On-Premise
 15.6 Historic and Forecasted Market Size By Interoperability Levels
  15.6.1 Foundational
  15.6.2 Structural
  15.6.3 Semantic
  15.6.4 Organizational
 15.7 Historic and Forecasted Market Size By End-User
  15.7.1 Hospitals
  15.7.2 Pharmacies
  15.7.3 Clinics
  15.7.4 Payers
  15.7.5 Ambulatory Surgical Centres
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET COMPETITIVE RIVALRY
TABLE 005. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET THREAT OF NEW ENTRANTS
TABLE 006. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET THREAT OF SUBSTITUTES
TABLE 007. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY TYPE
TABLE 008. SOFTWARE MARKET OVERVIEW (2016-2028)
TABLE 009. SERVICES MARKET OVERVIEW (2016-2028)
TABLE 010. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY DEPLOYMENT
TABLE 011. CLOUD-BASED MARKET OVERVIEW (2016-2028)
TABLE 012. ON-PREMISE MARKET OVERVIEW (2016-2028)
TABLE 013. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY INTEROPERABILITY LEVELS
TABLE 014. FOUNDATIONAL MARKET OVERVIEW (2016-2028)
TABLE 015. STRUCTURAL MARKET OVERVIEW (2016-2028)
TABLE 016. SEMANTIC MARKET OVERVIEW (2016-2028)
TABLE 017. ORGANIZATIONAL MARKET OVERVIEW (2016-2028)
TABLE 018. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY END-USER
TABLE 019. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 020. PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 021. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 022. PAYERS MARKET OVERVIEW (2016-2028)
TABLE 023. AMBULATORY SURGICAL CENTRES MARKET OVERVIEW (2016-2028)
TABLE 024. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 025. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT (2016-2028)
TABLE 026. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVELS (2016-2028)
TABLE 027. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER (2016-2028)
TABLE 028. N HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 029. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 030. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT (2016-2028)
TABLE 031. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVELS (2016-2028)
TABLE 032. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER (2016-2028)
TABLE 033. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 034. ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 035. ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT (2016-2028)
TABLE 036. ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVELS (2016-2028)
TABLE 037. ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER (2016-2028)
TABLE 038. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVELS (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER (2016-2028)
TABLE 043. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 044. SOUTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 045. SOUTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY DEPLOYMENT (2016-2028)
TABLE 046. SOUTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVELS (2016-2028)
TABLE 047. SOUTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END-USER (2016-2028)
TABLE 048. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 049. ALLSCRIPTS HEALTHCARE LLC: SNAPSHOT
TABLE 050. ALLSCRIPTS HEALTHCARE LLC: BUSINESS PERFORMANCE
TABLE 051. ALLSCRIPTS HEALTHCARE LLC: PRODUCT PORTFOLIO
TABLE 052. ALLSCRIPTS HEALTHCARE LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. NXGN MANAGEMENT LLC: SNAPSHOT
TABLE 053. NXGN MANAGEMENT LLC: BUSINESS PERFORMANCE
TABLE 054. NXGN MANAGEMENT LLC: PRODUCT PORTFOLIO
TABLE 055. NXGN MANAGEMENT LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. EMIS HEALTH: SNAPSHOT
TABLE 056. EMIS HEALTH: BUSINESS PERFORMANCE
TABLE 057. EMIS HEALTH: PRODUCT PORTFOLIO
TABLE 058. EMIS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. EPIC SYSTEMS CORPORATION: SNAPSHOT
TABLE 059. EPIC SYSTEMS CORPORATION: BUSINESS PERFORMANCE
TABLE 060. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 061. EPIC SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. INFOR INC.: SNAPSHOT
TABLE 062. INFOR INC.: BUSINESS PERFORMANCE
TABLE 063. INFOR INC.: PRODUCT PORTFOLIO
TABLE 064. INFOR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. VISOLVE INC.: SNAPSHOT
TABLE 065. VISOLVE INC.: BUSINESS PERFORMANCE
TABLE 066. VISOLVE INC.: PRODUCT PORTFOLIO
TABLE 067. VISOLVE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. CERNER CORPORATION: SNAPSHOT
TABLE 068. CERNER CORPORATION: BUSINESS PERFORMANCE
TABLE 069. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 070. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. INTERSYSTEMS CORPORATION: SNAPSHOT
TABLE 071. INTERSYSTEMS CORPORATION: BUSINESS PERFORMANCE
TABLE 072. INTERSYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 073. INTERSYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. ORION HEALTH GROUP LIMITED: SNAPSHOT
TABLE 074. ORION HEALTH GROUP LIMITED: BUSINESS PERFORMANCE
TABLE 075. ORION HEALTH GROUP LIMITED: PRODUCT PORTFOLIO
TABLE 076. ORION HEALTH GROUP LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. JITTERBIT INC.: SNAPSHOT
TABLE 077. JITTERBIT INC.: BUSINESS PERFORMANCE
TABLE 078. JITTERBIT INC.: PRODUCT PORTFOLIO
TABLE 079. JITTERBIT INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. KONINKLIJKE PHILIPS N.V.: SNAPSHOT
TABLE 080. KONINKLIJKE PHILIPS N.V.: BUSINESS PERFORMANCE
TABLE 081. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 082. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. INTERFACEWARE INC.: SNAPSHOT
TABLE 083. INTERFACEWARE INC.: BUSINESS PERFORMANCE
TABLE 084. INTERFACEWARE INC.: PRODUCT PORTFOLIO
TABLE 085. INTERFACEWARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. OSP LABS: SNAPSHOT
TABLE 086. OSP LABS: BUSINESS PERFORMANCE
TABLE 087. OSP LABS: PRODUCT PORTFOLIO
TABLE 088. OSP LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 089. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 090. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 091. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY TYPE
FIGURE 012. SOFTWARE MARKET OVERVIEW (2016-2028)
FIGURE 013. SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 014. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY DEPLOYMENT
FIGURE 015. CLOUD-BASED MARKET OVERVIEW (2016-2028)
FIGURE 016. ON-PREMISE MARKET OVERVIEW (2016-2028)
FIGURE 017. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY INTEROPERABILITY LEVELS
FIGURE 018. FOUNDATIONAL MARKET OVERVIEW (2016-2028)
FIGURE 019. STRUCTURAL MARKET OVERVIEW (2016-2028)
FIGURE 020. SEMANTIC MARKET OVERVIEW (2016-2028)
FIGURE 021. ORGANIZATIONAL MARKET OVERVIEW (2016-2028)
FIGURE 022. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY END-USER
FIGURE 023. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 024. PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 025. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 026. PAYERS MARKET OVERVIEW (2016-2028)
FIGURE 027. AMBULATORY SURGICAL CENTRES MARKET OVERVIEW (2016-2028)
FIGURE 028. NORTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. EUROPE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. ASIA PACIFIC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. MIDDLE EAST & AFRICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. SOUTH AMERICA HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)